Cargando…
A Pilot Study Evaluating the Effects of Magtrace® for Sentinel Node Biopsy in Breast Cancer Patients Regarding Care Process Optimization, Reimbursement, Surgical Time, and Patient Comfort Compared With Standard Technetium(99)
BACKGROUND: Sentinel lymph node biopsy after technetium-99 (Tc(99)) localization is a mainstay of oncologic breast surgery. The timing of Tc(99) injection can complicate operating room schedules, which can cause increasing overall costs of care and patient discomfort. METHODS: This study compared 59...
Autores principales: | Shams, Sina, Lippold, Kai, Blohmer, Jens Uwe, Röhle, Robert, Kühn, Friedrich, Karsten, Maria Margarete |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119277/ https://www.ncbi.nlm.nih.gov/pubmed/33263157 http://dx.doi.org/10.1245/s10434-020-09280-1 |
Ejemplares similares
-
Comparison of Post-injection Site Pain Between Technetium Sulfur Colloid and Technetium Tilmanocept in Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy
por: Unkart, Jonathan T., et al.
Publicado: (2015) -
Randomized Comparison of Near-infrared Fluorescence Imaging Using Indocyanine Green and 99(m) Technetium With or Without Patent Blue for the Sentinel Lymph Node Procedure in Breast Cancer Patients
por: van der Vorst, Joost R., et al.
Publicado: (2012) -
ASO Author Reflections: Non-radioactive Sentinel Node Localization with Superparamagnetic Iron Oxide in Clinically Node-Negative Breast Cancer Patients: A Possibility for Improvement of the Care Pathway
por: Karsten, Maria Margarete, et al.
Publicado: (2020) -
Randomized comparison between indocyanine green fluorescence plus (99m)technetium and (99m)technetium alone methods for sentinel lymph node biopsy in breast cancer
por: Vermersch, Charlotte, et al.
Publicado: (2019) -
Intraoperative indocyanine green fluorescence imaging in breast surgery
por: Kühn, Friedrich, et al.
Publicado: (2020)